Investigating the Effect of Ligand Amount and Injected Therapeutic Activity: A Simulation Study for ¹⁷⁷Lu-Labeled PSMA-Targeting Peptides

• Peter Kletting ,

  * E-mail: peter.kletting@uniklinik-ulm.de

  Affiliation Department of Nuclear Medicine, Ulm University, Ulm, Germany

  http://orcid.org/0000-0003-3654-3667

  ⨯
• Christiane Schuchardt,

  Affiliation THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging (PET/CT), Zentralklinik Bad Berka, Bad Berka, Germany

  ⨯
• Harshad R. Kulkarni,

  Affiliation THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging (PET/CT), Zentralklinik Bad Berka, Bad Berka, Germany

  ⨯
• Mostafa Shahinfar,

  Affiliation THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging (PET/CT), Zentralklinik Bad Berka, Bad Berka, Germany

  ⨯
• Aviral Singh,

  Affiliation THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging (PET/CT), Zentralklinik Bad Berka, Bad Berka, Germany

  ⨯
• Gerhard Glatting,

  Affiliation Medical Radiation Physics/Radiation Protection, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany

  ⨯
• Richard P. Baum,

  Affiliation THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging (PET/CT), Zentralklinik Bad Berka, Bad Berka, Germany

  ⨯
• Ambros J. Beer

  Affiliation Department of Nuclear Medicine, Ulm University, Ulm, Germany

  ⨯